GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Advanced Enzyme Technologies ADVENZYMES.NS · INR

Materials · NSE · 🇮🇳 India

Compare

282.10

+0.64%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

7 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 448.80

Low
444.40
Average
448.80
Median
448.80
High
462.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028
Revenue₹8.70bn₹10.15bn
Revenue, highest₹8.70bn₹10.15bn
Revenue, lowest₹8.70bn₹10.15bn
Earnings per share14.8017.50
Earnings per share, highest14.8017.50
Earnings per share, lowest14.8017.50
Analysts11

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2025Q3 2025Q1 2024Q4 2024Q4 2023Q3 2024Q3 2023
Forecast3.984.083.803.883.303.372.70
Reported2.373.363.883.883.743.743.08
Difference-40.4%-17.6%+2.1%+0.1%+13.3%+11.1%+14.1%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 9.8% a year over 10 years. Return on equity 10.3%.

Model fair value

404.02

From earnings 404.02, from revenue 383.13.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.